A detailed history of Virtus Fund Advisers, LLC transactions in Vericel Corp stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 918 shares of VCEL stock, worth $52,941. This represents 0.19% of its overall portfolio holdings.

Number of Shares
918
Previous 918 -0.0%
Holding current value
$52,941
Previous $42,000 9.52%
% of portfolio
0.19%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$41.71 - $52.9 $6,339 - $8,040
152 Added 19.84%
918 $42,000
Q2 2023

Aug 14, 2023

BUY
$29.0 - $38.37 $22,214 - $29,391
766 New
766 $28,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.72B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Virtus Fund Advisers, LLC Portfolio

Follow Virtus Fund Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus Fund Advisers, LLC with notifications on news.